These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 20383708)

  • 41. The Design, Synthesis, and Biological Activities of Pyrrole-Based Carboxamides: The Novel Tubulin Inhibitors Targeting the Colchicine-Binding Site.
    Boichuk S; Galembikova A; Syuzov K; Dunaev P; Bikinieva F; Aukhadieva A; Zykova S; Igidov N; Gankova K; Novikova M; Kopnin P
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer.
    Colley HE; Muthana M; Danson SJ; Jackson LV; Brett ML; Harrison J; Coole SF; Mason DP; Jennings LR; Wong M; Tulasi V; Norman D; Lockey PM; Williams L; Dossetter AG; Griffen EJ; Thompson MJ
    J Med Chem; 2015 Dec; 58(23):9309-33. PubMed ID: 26580420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DAT-230, a novel microtubule inhibitor, exhibits potent anti-tumor activity by inducing G2/M phase arrest, apoptosis in vitro and perfusion decrease in vivo to HT-1080.
    Qiao F; Zuo D; Shen X; Qi H; Wang H; Zhang W; Wu Y
    Cancer Chemother Pharmacol; 2012 Aug; 70(2):259-70. PubMed ID: 22752214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, molecular properties prediction and biological evaluation of indole-vinyl sulfone derivatives as novel tubulin polymerization inhibitors targeting the colchicine binding site.
    Li W; Sun H; Xu F; Shuai W; Liu J; Xu S; Yao H; Ma C; Zhu Z; Xu J
    Bioorg Chem; 2019 Apr; 85():49-59. PubMed ID: 30599412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques.
    Jekerle V; Klinkhammer W; Scollard DA; Breitbach K; Reilly RM; Piquette-Miller M; Wiese M
    Int J Cancer; 2006 Jul; 119(2):414-22. PubMed ID: 16646006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 3-Aroylindoles display antitumor activity in vitro and in vivo: Effects of N1-substituents on biological activity.
    Lee HY; Lee JF; Kumar S; Wu YW; HuangFu WC; Lai MJ; Li YH; Huang HL; Kuo FC; Hsiao CJ; Cheng CC; Yang CR; Liou JP
    Eur J Med Chem; 2017 Jan; 125():1268-1278. PubMed ID: 27886544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monomethyl Auristatin E Phosphate Inhibits Human Prostate Cancer Growth.
    Cunningham D; Parajuli KR; Zhang C; Wang G; Mei J; Zhang Q; Liu S; You Z
    Prostate; 2016 Nov; 76(15):1420-30. PubMed ID: 27325602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.
    Loganzo F; Discafani CM; Annable T; Beyer C; Musto S; Hari M; Tan X; Hardy C; Hernandez R; Baxter M; Singanallore T; Khafizova G; Poruchynsky MS; Fojo T; Nieman JA; Ayral-Kaloustian S; Zask A; Andersen RJ; Greenberger LM
    Cancer Res; 2003 Apr; 63(8):1838-45. PubMed ID: 12702571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NMK-TD-100, a novel microtubule modulating agent, blocks mitosis and induces apoptosis in HeLa cells by binding to tubulin.
    Bhattacharya S; Kumar NM; Ganguli A; Tantak MP; Kumar D; Chakrabarti G
    PLoS One; 2013; 8(10):e76286. PubMed ID: 24116100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Poloxamines display a multiple inhibitory activity of ATP-binding cassette (ABC) transporters in cancer cell lines.
    Cuestas ML; Sosnik A; Mathet VL
    Mol Pharm; 2011 Aug; 8(4):1152-64. PubMed ID: 21591727
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel nicotinoyl pyrazoline derivates bearing N-methyl indole moiety as antitumor agents: Design, synthesis and evaluation.
    Chen K; Zhang YL; Fan J; Ma X; Qin YJ; Zhu HL
    Eur J Med Chem; 2018 Aug; 156():722-737. PubMed ID: 30041136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigation of anti-tumor mechanisms of K2154: characterization of tubulin isotypes, mitotic arrest and apoptotic machinery.
    Lu PH; Kung FL; Kuo SC; Chueh SC; Guh JH
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):223-33. PubMed ID: 17102938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticancer properties of indole derivatives as IsoCombretastatin A-4 analogues.
    Pecnard S; Hamze A; Bignon J; Prost B; Deroussent A; Gallego-Yerga L; Peláez R; Paik JY; Diederich M; Alami M; Provot O
    Eur J Med Chem; 2021 Nov; 223():113656. PubMed ID: 34171660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Promising Microtubule Inhibitor Deoxypodophyllotoxin Exhibits Better Efficacy to Multidrug-Resistant Breast Cancer than Paclitaxel via Avoiding Efflux Transport.
    Zang X; Wang G; Cai Q; Zheng X; Zhang J; Chen Q; Wu B; Zhu X; Hao H; Zhou F
    Drug Metab Dispos; 2018 May; 46(5):542-551. PubMed ID: 29523600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of C
    Guggilapu SD; Lalita G; Reddy TS; Prajapti SK; Nagarsenkar A; Ramu S; Brahma UR; Lakshmi UJ; Vegi GMN; Bhargava SK; Babu BN
    Eur J Med Chem; 2017 Mar; 128():1-12. PubMed ID: 28131777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
    Farabegoli F; Papi A; Bartolini G; Ostan R; Orlandi M
    Phytomedicine; 2010 Apr; 17(5):356-62. PubMed ID: 20149610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel colchicine-based microtubule inhibitor exhibits potent antitumor activity by inducing mitochondrial mediated apoptosis in MIA PaCa-2 pancreatic cancer cells.
    Kumar A; Singh B; Mahajan G; Sharma PR; Bharate SB; Mintoo MJ; Mondhe DM
    Tumour Biol; 2016 Oct; 37(10):13121-13136. PubMed ID: 27449046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate Cancer.
    Liao VWY; Kumari A; Narlawar R; Vignarajan S; Hibbs DE; Panda D; Groundwater PW
    Mol Pharmacol; 2020 Jun; 97(6):409-422. PubMed ID: 32241960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma.
    Mundra V; Peng Y; Kumar V; Li W; Miller DD; Mahato RI
    Drug Deliv Transl Res; 2015 Jun; 5(3):199-208. PubMed ID: 25924699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CWF-145, a novel synthetic quinolone derivative exerts potent antimitotic activity against human prostate cancer: Rapamycin enhances antimitotic drug-induced apoptosis through the inhibition of Akt/mTOR pathway.
    Hung CM; Lin YC; Liu LC; Kuo SC; Ho CT; Way TD
    Chem Biol Interact; 2016 Dec; 260():1-12. PubMed ID: 27769712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.